175 related articles for article (PubMed ID: 8677447)
21. Ifosfamide treatment of advanced ovarian cancer.
Yazigi R; Wild R; Madrid J; Arraztoa J
Obstet Gynecol; 1984 Feb; 63(2):163-6. PubMed ID: 6694809
[TBL] [Abstract][Full Text] [Related]
22. Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent.
Markman M; Kennedy A; Sutton G; Hurteau J; Webster K; Peterson G; Kulp B; Belinson J
Gynecol Oncol; 1998 Aug; 70(2):272-4. PubMed ID: 9740704
[TBL] [Abstract][Full Text] [Related]
23. Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy.
Munoz R; Man S; Shaked Y; Lee CR; Wong J; Francia G; Kerbel RS
Cancer Res; 2006 Apr; 66(7):3386-91. PubMed ID: 16585158
[TBL] [Abstract][Full Text] [Related]
24. Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: a phase I-II study.
Genre D; Viens P; Gravis G; Bertucci F; Cowen D; Novakovitch G; Derméche S; Chabannon C; Oziel-Taieb S; Camerlo J; Houvenaeghel G; Jacquemier J; Maraninchi D
Anticancer Res; 2000; 20(3B):2033-40. PubMed ID: 10928147
[TBL] [Abstract][Full Text] [Related]
25. Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.
Shinohara N; Harabayashi T; Suzuki S; Nagao K; Seki H; Murakumo M; Mitsuhashi K; Demura T; Nagamori S; Matsuyama H; Naito K; Nonomura K
Cancer Chemother Pharmacol; 2006 Sep; 58(3):402-7. PubMed ID: 16416335
[TBL] [Abstract][Full Text] [Related]
26. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide "metronomic" chemotherapy for palliative treatment of a young patient with advanced epithelial ovarian cancer.
Samaritani R; Corrado G; Vizza E; Sbiroli C
BMC Cancer; 2007 Apr; 7():65. PubMed ID: 17433113
[TBL] [Abstract][Full Text] [Related]
28. Testicular function of survivors of childhood cancer: a comparative study between ifosfamide- and cyclophosphamide-based regimens.
Ridola V; Fawaz O; Aubier F; Bergeron C; de Vathaire F; Pichon F; Orbach D; Gentet JC; Schmitt C; Dufour C; Oberlin O
Eur J Cancer; 2009 Mar; 45(5):814-8. PubMed ID: 19216070
[TBL] [Abstract][Full Text] [Related]
29. Ifosfamide vs cyclophosphamide in cancer therapy.
Weiss RB
Oncology (Williston Park); 1991 May; 5(5):67-76; discussion 76-82, 84-6. PubMed ID: 1653004
[TBL] [Abstract][Full Text] [Related]
30. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
Nonomura N; Oka D; Nishimura K; Nakayama M; Inoue H; Mizutani Y; Miki T; Okuyama A
Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
[TBL] [Abstract][Full Text] [Related]
31. The role of ifosfamide in small cell lung cancer.
Loehrer PJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):40-4. PubMed ID: 8711501
[TBL] [Abstract][Full Text] [Related]
32. Topotecan and ifosfamide as salvage treatment in advanced ovarian cancer.
Chiara S; Tognoni A; Pastrone I; Tomasello L; Brema F; Di Costanzo G; Folco U; Pronzato P;
Gynecol Oncol; 2004 May; 93(2):474-8. PubMed ID: 15099965
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
[TBL] [Abstract][Full Text] [Related]
34. Phase I trial of dose-escalated paclitaxel and carboplatin in combination with ifosfamide and filgrastim: preliminary results.
Palackdharry CS
Semin Oncol; 1996 Jun; 23(3 Suppl 6):78-83. PubMed ID: 8677455
[TBL] [Abstract][Full Text] [Related]
35. [CMF or CAF combination chemotherapy for breast cancer].
Ota J
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1886-90. PubMed ID: 8978791
[TBL] [Abstract][Full Text] [Related]
36. Ifosfamide in the treatment of pediatric malignancies.
Voûte PA; van den Berg H; Behrendt H; Michiels E; de Kraker J
Semin Oncol; 1996 Jun; 23(3 Suppl 7):8-11. PubMed ID: 8711502
[TBL] [Abstract][Full Text] [Related]
37. Ifosfamide in advanced/disseminated breast cancer.
Sorio R; Lombardi D; Spazzapan S; La Mura N; Tabaro G; Veronesi A
Oncology; 2003; 65 Suppl 2():55-8. PubMed ID: 14586149
[TBL] [Abstract][Full Text] [Related]
38. Activity of ifosfamide in breast cancer.
Hortobagyi GN
Semin Oncol; 1992 Dec; 19(6 Suppl 12):36-41. PubMed ID: 1485173
[TBL] [Abstract][Full Text] [Related]
39. Lethal anuria complicating high dose ifosfamide chemotherapy in a breast cancer patient with an impaired renal function.
Richard V; Piccart M; Paridaens R; Sculier JP
Rev Med Brux; 1990 Mar; 11(3):64-7. PubMed ID: 2320800
[TBL] [Abstract][Full Text] [Related]
40. [Sequential course and prospective management of ifosfamide-induced multi-organ toxicity].
Mollenkopf A; du Bois A; Meerpohl HG
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):525-8. PubMed ID: 9036065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
